Skip links

GSS EU Science Funding Gateway

Advanced biomaterials for the Health Care (IA)

Summary

Cluster 4 promotes investments that will shape competitive and trusted technologies for a European industry enabling production and consumption to respect the planet’s boundaries and maximising the benefits for all parts of society in the variety of social, economic and territorial contexts in Europe. This will build a competitive, digital, low-carbon and circular industry, ensure sustainable supply of raw materials, develop advanced materials and provide the basis for advances and innovation in global challenges to society.

Programme Name

Horizon Europe (2021-2027)

Programme Description

Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.

Programme Details

Call

Advanced biomaterials for the Health Care (IA)

Detailed Call Description

Proposals should address at least four of the following activities:

  • To enable a fast development of new advanced novel injectable biomaterials, digital tools such as modelling, simulation and characterisation techniques (including those provided by analytical infrastructures) assisted by advanced methods e.g. physics-based methods, machine learning or artificial intelligence.
  • The innovation market of medical applications is fast growing and dependent on advanced biocompatible materials that can be printed or injected. The 4D materials will change their 3D structures after external impact such as thermic, electric, mechanical or radiation treatment.
  • Proposals shall demonstrate new engineering strategies that present functional characteristics beyond bio-compatibility, and express properties that can be used to control the physiological environment (shape-memory, self-healing properties) and induce a response.
  • Proposals shall address biomaterials with antibacterial properties contributing to the widespread bottleneck of antimicrobial resistance often encountered in clinical care
  • Demonstrate the scaling of injectable hydrogels, including those made of nanocomposite, natural and synthetic polymer-based biomaterials, bone cements, bio-ceramics and electronics.
  • The design for circularity has to develop, when relevant, bio-degradable or bio-absorbable biomaterials that are gradually eliminated by the body after fulfilling a purpose.

The biomaterials used should be safe and sustainable by design (SSbD), taking also into account any specific medical requirements.

Programme Category
EU Competitive Programmes
Total Budget
€31 000 000
Thematic Categories
  • Environment and Climate Change
  • Health
  • Industry
  • Information and Communication Technologies
  • Other Thematic Category
  • Research, Technological Development and Innovation
  • Small-Medium Enterprises and Competitiveness
Eligibility for Participation
  • Large Enterprises
  • Private Bodies
  • Researchers/Research Centers/Institutions
  • State-owned Enterprises
Call Opening Date
19/09/2023
Call Closing Date
07/02/2024
National Contact Point(s)

Research and Innovation Foundation

29a Andrea Michalakopoulou, 1075 Nicosia,
P.B. 23422, 1683 Nicosia
Telephone: +357 22205000
Fax: +357 22205001
Email: support@research.org.cy
Websitehttps://www.research.org.cy/en/

Contact Persons:
Dr Angelos Ntantos
Scientific Officer
Telephone: +357 22 205 033
Email: antantos@research.org.cy

Mr George Christou
Scientific Officer
Telephone: +357 22 205 030
Email: gchristou@research.org.cy

Website
Funding&Tenders
This website uses cookies to improve your web experience.
Home
Account
Cart
Search
Explore
Drag